WIN 66306
WIN 66306
$255.00 - 1 mg
$895.00 - 5 mg
All prices in Australian dollars
- Code
- BIA-W2527
- Synonyms
- Cyclo[glycyl-L-tryptophyl-L-prolylglycyl-L-valylglycyl-(βR)-β-hydroxy-3-(3-methyl-2-butenyl)-L-tyrosyl]
- CAS #
- 151928-32-4
- Molecular Formula
- C41H52N8O9
- Molecular Weight
- 800.9
- Purity
- >95% by HPLC
- Long Term Storage
- -20°C
- Solubility
- Soluble in methanol or DMSO
Download Data Sheets
Application Notes
WIN 66306 is a cyclic peptide discovered during a search for inhibitors of Substance P binding to neurokinin (NK) receptors by researchers at Sterling Winthrop Pharmaceuticals in 1994. WIN 66306, isolated from Aspergillus sp., is active at both the NK1 and NK2 receptor subtypes and is more active against human NK1 receptors than rat NK1 receptors.
References
- WIN 66306, a new neurokinin antagonist producted by an Aspergillus species; Fermentation, isolation and physicochemical properties. Barrow C.J. et al. J Antibiot. 1994, 47, 1182.
- Structure determination, pharmacological evaluation and structure-activity relationship studies of a new cyclic peptide Substance P antagonist containing the new amino acid, 3-prenyl-β-hydroxytyrosine, isolated from Aspergillus flavus. Barrow C.J. et al. J Med Chem. 1994, 37, 356.